Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease

European Journal of Vascular and Endovascular Surgery

Volumn 14, Issue 1, 1997, Pages 17-23

  Cheng, S W K ^a   Ting, A C W ^a   Wong, J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Lipoprotein (a); Peripheral vascular disease; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PLASMINOGEN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPERTENSION; LEG; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PAIN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SMOKING; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; ULCER;

EID: 0030794879     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(97)80220-1     Document Type: Article

References (27)

1. Mölgaard J Klausen IC Lassvik C Faergeman O Gerdes LU Olsson AG Significant association between low-molecular-weight apolipoprotein (a) isoforms and intermittent claudication Arterioscler Thromb 12 1992 895 901
2. Widmann MD Sumpio BE Lipoprotein (a): a risk factor for peripheral vascular disease Ann Vasc Surg 7 1993 446 451
3. Pedro-Botet J Senti M Auguet T Apolipoprotein (a) genetic polymorphism and serum lipoprotein (a) concentration in patients with peripheral vascular disease Atherosclerosis 104 1993 87 94
4. Levy PJ Gonzalez F Hornung CA Chang WW Haynes JL Rush DS A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis J Vasc Surg 23 1996 36 45
5. Valentine RJ Kaplan HS Green R Jacobsen DW Myers SI Clagett GP Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective, controlled analysis J Vasc Surg 23 1996 53 63
6. α-CBZ-L-Lysine p-nitrohenyl ester as substrate Anal Biochem 65 1975 500 506
7. Levine DM Sloan BJ Donner JE Lorenz JD Heinzerling R Automated measurement of Lp(a) by immunoturbidimetric analysis Int J Clin Lab Res 22 1992 173 178
8. Rutherford RB Flanigan DP Gupta SK Suggested standards for reports dealing with lower extremity ischemia J Vasc Surg 4 1986 80 94
9. Kostner GM Avogaro P Cazzolato G Lipoprotein (a) and the risk for myocardial infarction Atherosclerosis 38 1981 51 61
10. Sandkamp M Funke H Schulte H Köhler E Assmann G Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age Clin Chem 36 1990 20 23
11. Ghilain JM Parfonry A Kozyreff V Lipoprotein (a), cholesterol, and coronary heart diseases Lancet 2 1988 963
12. Koltringer P Jurgens G A dominant role of lipoprotein (a) in the investigation and evaluation of parameters indicating development of cervical atherosclerosis Atherosclerosis 58 1985 187 198
13. Walton KW Hitchens J Magnani HN A study of methods of identification and estimation of Lp (a) lipoprotein and of its significance in health, hyperlipidemia and atherosclerosis Atherosclerosis 9 1989 579 592
14. Houlson R Friedl W Biochemistry and clinical significance of lipoprotein (a) Ann Clin Biochem 25 1988 499 503
15. Frank SL Klisak I Sparks RS The apoprotein (a) gene resides on human chromosome 6q 26–27 in close proximity to the homologous gene for plasminogen Hum Genet 79 1988 352 356
16. Miles LA Fless GM Levin EG A potential basis for the thrombotic risks associated with lipoprotein (a) Nature 339 1989 310 313
17. Nago N Kayaba K Hiraoka J Lipoprotein (a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study Am J Epidemiol 141 1995 815 821
18. Jenner JL Ordovas JM Lamon-Fava S Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study Circulation 87 1993 1135 1141
19. Helmhold M Bigge J Muche R Contribution of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation J Lipid Res 32 1991 1919 1928
20. Woo J Lau E Lam CWK Hypertension, lipoprotein (a), and apolipoprotein A-1 as risk factors for stroke in Chinese Stroke 22 1991 203 208
21. Woo J Ho SC Wong SL Lipids, lipoproteins and other coronary risk factors in Chinese male survivors of myocardial infarction Int J Cardiol 39 1993 195 202
22. Kario K Matsuo T Imiya M Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects 75 years of age Am J Cardiol 73 1994 1187 1190
23. Utermann G The mysteries of lipoprotein (a) Science 246 1989 904 910
24. Maher VM Brown BG Marcovina SM Hillger LA Zhao XQ Albers JJ Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein (a) JAMA 274 1995 1771 1774
25. Seed M O'Connor B Perombelon N O'Donnell M Reaveley D Knight BL The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover Atherosclerosis 101 1993 61 68
26. Sartori MT Patrassi GM Theodoridis P Perin A Pietrogrande F Girolami A Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds Blood Coagul Fibrinolys 5 1994 889 893
27. Helmhold M Bigge J Muche R Contribution of the apo(a) phenotype to plasma Lp(a) concentration shows considerable ethnic variation J Lipid Res 32 1991 1919 1928